TCL Archive FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview. November 7, 2003
TCL Archive How NCI’s Plans For Software Giveaway Sank In Scientific And Legal Disputes (Part Two In A Series About NCI’s Bioinformatics Venture caBIG). March 4, 2011
TCL Archive In Brief: Override Failure Would Leave Cancer Program With No Money or New Projects Of Any Kind January 23, 1976
TCL Archive In Brief: Hazleton Acquires Prime Labs, Primate Importer; Cullen UCLA Deputy Director July 30, 1976
